Journals / JAREM / 2019 / Cilt: 9 - Sayı: 3

Investigation of Lactobacillus Casei and Lactobacillus Acidophilus Amount at Gut Microbiota from Adult Type 1 Diabetes Mellitus Patients

Tip 1 Diyabet Hastalarının Bağırsak Mikrobiyotasında Lactobacillus Casei ve Lactobacillus Acidophilus Miktarının Araştırılması

Journal
JAREM
Pages
125–129
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This situation needs to be clarified with comprehensive studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study were to determine the amount of Lactobacillus acidophilus and Lactobacillus casei, which are considered to have protective roles among the host-gut microbiota due to their probiotic properties, by using real-time polymerase chain reaction (PCR) and to compare between adult patients with type 1 diabetes mellitus (T1DM) and healthy individuals.
📊
Key Findings & Data:Methods: Between January 2014 and October 2014, a total of 106 stool samples comprising those of 53 adult patients who were diagnosed with T1DM and those of 53 healthy individuals who presented to an endocrinology clinic were included in the study.
💡
Conclusion & Impact:This situation needs to be clarified with comprehensive studies.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study were to determine the amount of Lactobacillus acidophilus and Lactobacillus casei, which are considered to have protective roles among the host-gut microbiota due to their probiotic properties, by using real-time polymerase chain reaction (PCR) and to compare between adult patients with type 1 diabetes mellitus (T1DM) and healthy individuals. Methods: Between January 2014 and October 2014, a total of 106 stool samples comprising those of 53 adult patients who were diagnosed with T1DM and those of 53 healthy individuals who presented to an endocrinology clinic were included in the study. DNA was isolated from the stool samples and analyzed with specific primers for L. acidophilus and L. casei by real-time PCR. Statistical analyses, such as Mann-Whitney U test, were used to determine the difference among patients with T1DM and healthy individuals. Results: The mean age of patients with T1DM and healthy individuals participating in the study was 32.87±12.68. A statistically significant difference was observed in the body mass index (BMI) and levels of HbA1c and fasting blood sugar of patients with T1DM when compared to those of the healthy individuals (p 0.05). Conclusion: This study was the first to determine and compare the amounts of L. acidophilus and L. casei in the gut of patients with T1DM and healthy individuals. The amount of these bacteria with known probiotic activities is not different among patients with T1DM and healthy individuals, and there is no change in the amount of these bacteria in both the reciprocal triggering cycle of T1DM and gut microbiota. This situation needs to be clarified with comprehensive studies.

Özet

Amaç: Probiyotik özellikleri ile konakta koruyucu rolleri olduğu düşünülen Lactobacillus acidophilus ve Lactobacillus casei’nin erişkin tip 1 diyabet (T1DM) hastaları ve sağlıklı kontrol gruplarındaki bireylerin bağırsak mikrobiyotasındaki miktarlarının real-time PCR yöntemi kullanarak saptanması ve erişkin T1DM hastaları ve sağlıklı kontrol grupları arasında miktarlar açısından bir fark bulunup bulunmadığının belirlenerek, Tip 1 diyabet hastalarında bu probiyotik bakterilerin önemi hakkında bazı verilerin belirlenmesidir. Yöntemler: Çalışma, Ocak 2014-Ekim 2014 tarihleri arasında, T1DM tanısı almış olan 53 erişkin hastadan ve sağlıklı kontrol grubunu oluşturan 53 sağlıklı bireyden alınan 106 dışkı örneği ile gerçekleştirildi. Dışkı örneklerinden DNA izolasyonları gerçekleştirildi. Elde edilen DNA’lar L. acidophilus ve L. casei’ye spesifik primerler yardımıyla real-time PCR sisteminde çalışıldı. Sonuçların istatistiksel analizi Mann-Whitney U testi ile yapıldı. Bulgular: Çalışmamıza katılan tip 1 diyabet tanılı hastaların ve sağlıklı bireylerin ortalama yaşları 32,87±12,68’dir. T1DM hastalarında saptanan vücut kitle indeksi (VKI), HbA1c ve açlık kan şekeri düzeylerinin, sağlıklı kontrol grubuna göre istatistiksel olarak ileri derecede anlamlı fark gösterdiği belirlenmiştir (p 0,05). Sonuç: Bu çalışma ülkemizde, T1DM tanılı hastalar ve sağlıklı bireylerin bağırsak mikrobiyotasında L. acidophilus ve L. casei miktarlarının incelendiği ilk çalışmadır. Probiyotik etkinlikleri bilinen bu iki bakterinin ülkemiz erişkin T1DM’lu hastalarının bağırsak mikrobiyotasındaki miktarlarında, sağlıklı kontrollere göre fark bulunmamıştır. Görüşümüz, T1DM ile bağırsak mikrobiyotasının birbirini karşılıklı tetikleyen döngüsü içinde, bu bakterilerin eksikliği ya da fazlalığının büyük önem taşımayabileceği yönünde olmuştur. Bu durumun, daha kapsamlı çalışmalarla aydınlatılmasında yarar olduğu kanaatindeyiz.

🔖

Cite This Article

Demirci, M., KESKİN, F. E. T., TANER, Z., ÖZYAZAR, M., KOCAZEYBEK, B. S., TOKMAN, H. B. (2019). Investigation of Lactobacillus Casei and Lactobacillus Acidophilus Amount at Gut Microbiota from Adult Type 1 Diabetes Mellitus Patients. JAREM, Cilt: 9 - Sayı: 3, 125–129. https://ajindex.com/articles/186542

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Saleh NM, Raj SM, Smyth DJ, Wallace C, Howson JMM, Bell L, et al. Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 1 diabetes. Diabetes Metab res rev 2011
  2. [CrossRef] 2. Murri M, Leiva I, Gomez JM, Cardona F, Soriguer F, Tinahones FJ, et al. Gut microbiota in children with type 1 diabetes differs from that in healty children: a case control study. BMC Medicine 2013
  3. [CrossRef] 3. Gomes AC, Bueno AA, de Souza RGM, Mota JF. Gut microbiota, probiotics and diabetes. Nutrition Journal. 2014
  4. [CrossRef] 4. Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003
  5. [CrossRef] 5. Karlsson F, Tremaroli V, Nielsen J, Bäckhed F. Assessing the human gut microbiota in metabolic diseases. Diabetes 2013
  6. [CrossRef] 6. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004
  7. [CrossRef] 7. Sommer F, Bäckhed F. The gut microbiota--masters of host development and physiology. Nat Rev Microbiol 2013
  8. [CrossRef] 8. Ljungberg M, Korpela R, Ilonen J, Ludvigsson J, Vaarala O. Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes--the PRODIA study. Ann N Y Acad Sci 2006
  9. [CrossRef] 9. Parra K, Ferrer M, Pi-ero M, Barboza Y, Medina LM. Use of Lactobacillus acidophilus and Lactobacillus casei for a potential probiotic legume-based fermented product using pigeon pea (Cajanus cajan). J Food Prot 2013
  10. [CrossRef] 10. CDC. Distribution of Age at Diagnosis of Diabetes Among Adult Incident Cases Aged 18-79 Years. 2011. Available from: URL: http://www.cdc.gov/diabetes/statistics/age/fig1.htm. 11. Herbel SR, Von Nickisch-Rosenegk M, Kuhn M, Murugaiyan J, Wieler LH, Guenther S. Specific TaqMan Probes for the Identification and Quantification of Lactobacilli in Pharmaceuticals. J Prob Health 2014
  11. Monique H, Knol J. Quantitative Real-Time PCR Analysis of Fecal Lactobacillus Species in Infants Receiving a Prebiotic Infant Formula. App. Env. Mic 2006
  12. NIH HMP Working Group, Peterson J, Garges S, Giovanni M, McInnes P, Wang L, et al. The NIH Human Microbiome Project. Genome Res 2009
  13. [CrossRef] 14. Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, et al. Gut mic